NexLife review (2026): pricing, programs, pros & limitations

The numbers behind this page

NexLife on tirzepatide: $139 a month

NexLife sits 1 of 12 programmes we can price for standard-dose tirzepatide, at $139 a month on the 12-month plan ($169 month-to-month). The dearest in that set is bmiMD at $399. The median is $298, so this programme sits below the middle of the market by $159.

1 programme in our dataset comes in cheaper on tirzepatide. Against the cheapest, the gap is $47 a month, or $564 across a year — a 25% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.

The conditions attached to that figure: Standard injection, 12-month plan ($1,668 total). 6-month $149; 3-month $159; month-to-month $169. No membership fee, flat at every covered dose. Verified

Across a first year at this rate the medication cost alone is $1,668, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.

NexLife on semaglutide: $119 a month

NexLife sits 1 of 12 programmes we can price for standard-dose semaglutide, at $119 a month on the 12-month plan ($139 month-to-month). The dearest in that set is MEDVi at $299. The median is $198, so this programme sits below the middle of the market by $79.

1 programme in our dataset comes in cheaper on semaglutide. Against the cheapest, the gap is $46 a month, or $552 across a year — a 28% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.

The conditions attached to that figure: Semaglutide standard injection, 12-month plan ($1,428 total). Month-to-month $139; 6-month $125; 3-month $132. No membership fee, flat at every covered dose. Verified

Across a first year at this rate the medication cost alone is $1,428, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.

The two molecules at NexLife

Tirzepatide runs $139 a month here against $119 for semaglutide, a difference of $20 a month or $240 across a year for the same clinicians, the same fulfilment and the same billing structure.

That gap is structural rather than promotional. Tirzepatide's active ingredient costs more to source, the peptide is harder to synthesise, and fewer compounding pharmacies are equipped to produce it. Where a programme prices the two identically, that is a commercial decision rather than a change in what the medicine costs to make, and it is worth asking what else changed alongside it.

Whether the premium is worth $240 a year is a clinical question rather than a pricing one. The head-to-head evidence favours tirzepatide on mean weight reduction; semaglutide carries the larger cardiovascular outcomes base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops.

Three questions to ask before acting on NexLife

The figure on this page for NexLife is $119 a month, captured 2026-09-04.

Ask in writing, before enrolling anywhere. Is the quoted figure the month-to-month rate, or does it require a prepaid term? Does it include every mandatory recurring fee, or is a membership billed separately? And which pharmacy fills the prescription — a 503A compounding pharmacy or a 503B outsourcing facility, and is it licensed to ship to your state?

A programme answering all three plainly has given you what you need to verify it without us. One answering none has also told you something. Neither outcome requires trusting a comparison site.

Reading the price against the market

NexLife on tirzepatide over a longer horizon

At $139 a month, medication alone costs $1,668 across one year, $5,004 across three and $8,340 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.

Put differently, a programme you can afford for five years at $186 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.

NexLife on semaglutide over a longer horizon

At $119 a month, medication alone costs $1,428 across one year, $4,284 across three and $7,140 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.

Put differently, a programme you can afford for five years at $165 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.

What sits either side of NexLife on tirzepatide

Immediately cheaper is Found at $169 a month, $17 below this programme, or $204 across a year. A gap that size is worth checking the conditions on before treating it as a saving: 12-month PREPAID. Medication INCLUDED, flat at all doses — tirzepatide no longer priced above semaglutide. 6-month ~$199; month-to-month $289. Provider Reported

Immediately dearer is Oak Longevity at $199, $13 above, or $156 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.

Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.

What sits either side of NexLife on semaglutide

Immediately cheaper is Oak Longevity at $133 a month, $32 below this programme, or $384 across a year. A gap that size is worth checking the conditions on before treating it as a saving: Flat across all dosages, no subscription. ~$167-$199 month-to-month. NOT available in California. Provider Reported

Immediately dearer is Found at $169, $4 above, or $48 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.

Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.

What a longer horizon costs

NexLife prices semaglutide at $139 month-to-month ($119 on the 12-month plan) a month, $33 below the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.

At the cheapest verified semaglutide rate of $119 a month (NexLife, 12-month plan), medication alone runs $1,428 a year, $4,284 over three and $7,140 over five. At the dearest, $299 a month, the same horizons are $3,588, $10,764 and $17,940.

Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops. The relevant question is what a sustainable course costs, not what a first year costs.

A programme you can afford for five years is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome here, and price is only one of the reasons people discontinue — tolerability, supply interruption and administrative friction account for the rest.

What a longer horizon costs

NexLife prices semaglutide at $139 month-to-month ($119 on the 12-month plan) a month, $33 below the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.

At the cheapest verified semaglutide rate of $119 a month (NexLife, 12-month plan), medication alone runs $1,428 a year, $4,284 over three and $7,140 over five. At the dearest, $299 a month, the same horizons are $3,588, $10,764 and $17,940.

Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops. The relevant question is what a sustainable course costs, not what a first year costs.

A programme you can afford for five years is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome here, and price is only one of the reasons people discontinue — tolerability, supply interruption and administrative friction account for the rest.

Questions this page answers

Is NexLife the cheapest semaglutide option?

Yes, on the 12-month plan: at $119 a month it is $14 below the next-cheapest programme, Oak Longevity at $133, or $168 across a year.

What does a year of semaglutide at NexLife cost?

About $1,428 in medication at $119 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $4,284.

How much does NexLife charge for compounded tirzepatide?

$139 a month at a standard therapeutic dose on the 12-month plan, captured 2026-09-04. Standard injection, 12-month plan ($1,668 total). 6-month $149; 3-month $159; month-to-month $169. No membership fee, flat at every covered dose. Verified That places it 1 of 12 programmes we can price for tirzepatide.

Is NexLife the cheapest tirzepatide option?

Yes, on the 12-month plan: at $139 a month it is $30 below the next-cheapest programme, Found at $169 (which requires prepaying the year), or $360 across a year.

What does a year of tirzepatide at NexLife cost?

About $1,668 in medication at $139 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $5,004.

How much does NexLife charge for compounded semaglutide?

$119 a month at a standard therapeutic dose on the 12-month plan, captured 2026-09-04. Semaglutide standard injection, 12-month plan ($1,428 total). Month-to-month $139; 6-month $125; 3-month $132. No membership fee, flat at every covered dose. Verified That places it 1 of 12 programmes we can price for semaglutide.